Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  SIX SWISS EXCHANGE AG  >  Roche Holding Ltd.       CH0012032048

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( CHF)
Sales 2016 51 095 M
EBIT 2016 17 589 M
Net income 2016 11 225 M
Debt 2016 11 033 M
Yield 2016 3,63%
Sales 2017 53 669 M
EBIT 2017 18 758 M
Net income 2017 12 390 M
Debt 2017 6 149 M
Yield 2017 3,85%
P/E ratio 2016 18,28
P/E ratio 2017 16,42
EV / Sales2016 4,22x
EV / Sales2017 3,93x
Capitalization 204 612 M
More Financials
Company
Roche Holding AG operates as a research healthcare company.It operates through the following segments: Diagnostics and Pharmaceuticals.The pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience.The... 
Sector
Pharmaceuticals
Calendar
02/01 | 07:00amEarnings Release
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on ROCHE HOLDING LTD.
01/17 ROCHE : Multiplex System Addresses IHC Needs
01/16 Global Lycopene Market 2017 - DSM, BASF, NIPPON, Kagome, Bayer, KIRIN, Roche ..
01/13 ROCHE : Johnson & Johnson and Alstrom Syndrome UK Address Hot Topic of Paediatri..
01/12 FOUNDATION MEDICINE : to Present at the 35th Annual J.P. Morgan Healthcare Confe..
01/12 PTC THERAPEUTICS : Announces Initiation of FIREFISH Study in Infant Type I SMA P..
01/12 CHUGAI PHARMACEUTICAL : Reports Outline Peptide Receptors Study Findings from Ch..
01/12 KITE PHARMA : Enhances Commercial Expertise with the Appointment of Ian T. Clark..
01/12 PTC THERAPEUTICS : RG7916 Granted Orphan Drug Designation in the U.S. for the Tr..
01/11 ROCHE : A Miami Mission Saves Lives in Earthquake- and Hurricane-Ravaged Haiti
01/11 FOUNDATION MEDICINE : Preliminary Q4 Revenue Rises 11 Percent
More news
Sector news : Pharmaceuticals - NEC
01:56aDJBAYER : Will Keep Monsanto Jobs in U.S., Trump Team Says -- 2nd Update
12:05aDJAllergan Admits to Disclosure Violations During Valeant Bid
01/17 Allergan to pay $15 million over failing to disclose merger talks
01/17DJBAYER : Will Keep Monsanto Jobs in U.S., Trump Team Says -- Update
01/17DJBAYER : Will Keep Monsanto Jobs in U.S., Trump Team Says
More sector news : Pharmaceuticals - NEC
Advertisement
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 282  CHF
Spread / Average Target 19%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Severin Schwan Chief Executive Officer & Executive Director
Christoph Franz Chairman
Alan Hippe Chief Financial & Information Technology Officer
John Irving Bell Non-Executive Director
Andreas Oeri Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ROCHE HOLDING LTD.203 077
JOHNSON & JOHNSON-0.30%311 773
ROCHE HOLDING LTD.1.29%203 077
PFIZER INC.-1.29%197 343
NOVARTIS AG-2.70%187 856
MERCK & CO., INC.4.43%171 880
More Results